D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$404M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$361M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$327M |
| 4 |
Procter & Gamble
PG
|
+$313M |
| 5 |
Netflix
NFLX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Bank of America
BAC
|
+$405M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$236M |
| 4 |
Citigroup
C
|
+$219M |
| 5 |
SLB Ltd
SLB
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 9.11% |
| 2 | Healthcare | 7.95% |
| 3 | Consumer Discretionary | 7.93% |
| 4 | Financials | 7.4% |
| 5 | Technology | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
EQT Corp
EQT
$33.2B
| $92.5M | 0.13% |
1,752,226
+741,224
| +73% | +$38.6M |
|
|
AGN
152
DELISTED
Allergan Inc
AGN
| $92.5M | 0.13% |
745,203
+533,015
| +251% | +$64.9M |
|
|
HSH
153
DELISTED
HILLSHIRE BRANDS CO
HSH
| $92.4M | 0.13% |
2,480,346
-21,976
| -0.9% | -$788K |
|
|
CLGX
154
DELISTED
Corelogic, Inc.
CLGX
| $91.7M | 0.13% |
3,053,248
+538,582
| +21% | +$17.7M |
|
|
SNDK
155
DELISTED
SANDISK CORP
SNDK
| $91.7M | 0.13% |
1,129,475
+865,405
| +328% | +$63.9M |
|
|
HNT
156
DELISTED
HEALTH NET INC
HNT
| $91.7M | 0.13% |
2,694,865
-718,182
| -21% | -$23.6M |
|
157
Adobe
ADBE
$89.5B
| $91.3M | 0.13% |
1,388,904
-156,248
| -10% | -$10M |
|
158
Simon Property Group
SPG
$74.5B
| $91.1M | 0.13% |
590,425
-119,699
| -17% | -$17.8M |
|
|
CELG
159
PUT
DELISTED
Celgene Corp
CELG
| $90.9M | 0.13% |
1,303,000
-258,200
| -17% | -$20.4M |
|
|
GRA
160
DELISTED
W.R. Grace & Co.
GRA
| $89.7M | 0.13% |
904,291
+298,043
| +49% | +$29.3M |
|
161
CALL
Johnson & Johnson
JNJ
$635B
| $89.4M | 0.13% |
910,500
| – | – |
|
162
Amazon
AMZN
$2.5T
| $89M | 0.13% |
5,291,380
-4,130,920
| -44% | -$76.7M |
|
163
Ford
F
$57.3B
| $88.5M | 0.13% |
5,675,552
-2,715,022
| -32% | -$42M |
|
|
KRFT
164
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $87.3M | 0.12% |
1,556,881
-340,460
| -18% | -$18.5M |
|
165
PUT
Starbucks
SBUX
$118B
| $87.1M | 0.12% |
2,373,400
-1,301,000
| -35% | -$48.1M |
|
166
CALL
ExxonMobil
XOM
$651B
| $86.3M | 0.12% |
883,100
+379,200
| +75% | +$36.1M |
|
167
Equity Lifestyle Properties
ELS
$12.8B
| $86.1M | 0.12% |
4,234,716
-229,056
| -5% | -$4.49M |
|
168
PUT
JPMorgan Chase
JPM
$939B
| $85.9M | 0.12% |
1,415,200
-775,400
| -35% | -$44.8M |
|
169
Omnicom Group
OMC
$22.7B
| $85.8M | 0.12% |
1,182,241
-114,665
| -9% | -$8.43M |
|
|
WBA
170
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $85.5M | 0.12% |
1,295,500
+177,500
| +16% | +$11.2M |
|
|
WNR
171
DELISTED
Western Refining Inc
WNR
| $85.2M | 0.12% |
2,207,932
+619,237
| +39% | +$24.3M |
|
172
NewMarket
NEU
$7.17B
| $85.1M | 0.12% |
217,815
+13,764
| +7% | +$4.88M |
|
173
Freeport-McMoran
FCX
$90B
| $84.9M | 0.12% |
2,568,612
-822,896
| -24% | -$27.4M |
|
174
Teva Pharmaceuticals
TEVA
$35.9B
| $84.6M | 0.12% |
1,601,875
+1,096,366
| +217% | +$50.7M |
|
175
Equity Residential
EQR
$25.4B
| $84.3M | 0.12% |
1,452,833
-812,928
| -36% | -$45.9M |
|
Similar funds
D.E. Shaw & Co's Q1 2014 Portfolio in Review
As of Q1 2014, D.E. Shaw & Co held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 9.1% of assets, up from 6.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Veren worth $53.3M.
- D.E. Shaw & Co's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
- D.E. Shaw & Co added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
- D.E. Shaw & Co's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
- D.E. Shaw & Co fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
- D.E. Shaw & Co opened 596 new positions and closed 795 in Q1 2014.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $70.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.